<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02261571</url>
  </required_header>
  <id_info>
    <org_study_id>CIMI-14-01-08</org_study_id>
    <nct_id>NCT02261571</nct_id>
  </id_info>
  <brief_title>Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer</brief_title>
  <official_title>A Pilot Study to Estimate the Efficacy of Moxibustion Stimulation at Abdominal Acupoints on Quality of Life in Cancer Patients Under Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Comprehensive and Integrative Medicine Institute of South Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Comprehensive and Integrative Medicine Institute of South Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most cancer patients experience multiple symptoms related to chemotherapy and use CAM&#xD;
      (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion&#xD;
      is traditional Korean medical therapeutic method and uses the heat generated by burning&#xD;
      herbal preparations containing Artemisia vulgaris to stimulated acupoint.&#xD;
&#xD;
      Herein, the investigators propose an open-label pilot study investigating the effectiveness&#xD;
      of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under&#xD;
      chemotherapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>functional Assessment of Cancer Therapy: General (FACT-G)</measure>
    <time_frame>change from baseline to 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>change from baseline to 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immune function</measure>
    <time_frame>change from baseline to 6 weeks</time_frame>
    <description>lymphocyte panel(CD3,4,8,19,26), WBC, Differential count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>M.D, Anderson symptom Inventory (MDASI)</measure>
    <time_frame>change from baseline to 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Moxibustion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A series of moxibustion sessions within six weeks from baseline with adjuvant chemotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants who will be allocated to waitlist will receive no moxibustion treatments throughout the 6 weeks while receiving adjuvant chemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moxibustion</intervention_name>
    <description>In the moxibustion treatment group, 3 moxibustion, 3 acupoints(CV12, CV8, CV54) will be heated with indirected moxibustion.&#xD;
The moxibustion will be removed when the patient feel hotness and require remove them</description>
    <arm_group_label>Moxibustion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnostic histopathology of cancer&#xD;
&#xD;
          -  Performance status of 0-2 on the European Cooperative Oncology Group (ECOG)&#xD;
             performance scale.&#xD;
&#xD;
          -  Patients on chemotherapy currently have plan to receive chemotherapy for more than 6&#xD;
             weeks.&#xD;
&#xD;
          -  Follow-up possible during the clinical trial&#xD;
&#xD;
          -  Informed signed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with Severe Heart disease and hypertension that is not controlled (systolic&#xD;
             blood pressure &gt;160 or Diastolic blood pressure &gt;100)&#xD;
&#xD;
          -  Patients with diabetes that is not controlled (FBST &gt;180 or BST&gt;250)&#xD;
&#xD;
          -  Patients with abdominal injury or severe ascites can't be received moxibustion therapy&#xD;
             on abdomen.&#xD;
&#xD;
          -  Hypersensitive section to moxibustion treatment&#xD;
&#xD;
          -  Inability to comprehend or express oneself in the Korean language&#xD;
&#xD;
          -  An Individual deemed to be ineligible by a physician&#xD;
&#xD;
          -  Refusal to participate in this trial or to provide informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hyun Jung Jung, KMD, Ph. D</last_name>
    <phone>+82537702082</phone>
    <email>koreancarmen@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Deagu Hanny University Medical center</name>
      <address>
        <city>Deagu</city>
        <zip>704-123</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Hyun Jung Jung, KMD, Ph. D</last_name>
    </contact>
    <investigator>
      <last_name>Kyung Soon Kim, KMD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Lee MS, Kang JW, Ernst E. Does moxibustion work? An overview of systematic reviews. BMC Res Notes. 2010 Nov 5;3:284. doi: 10.1186/1756-0500-3-284.</citation>
    <PMID>21054851</PMID>
  </reference>
  <reference>
    <citation>Lee MS, Choi TY, Park JE, Lee SS, Ernst E. Moxibustion for cancer care: a systematic review and meta-analysis. BMC Cancer. 2010 Apr 7;10:130. doi: 10.1186/1471-2407-10-130. Review.</citation>
    <PMID>20374659</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>October 2, 2014</study_first_submitted>
  <study_first_submitted_qc>October 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2014</study_first_posted>
  <last_update_submitted>October 9, 2014</last_update_submitted>
  <last_update_submitted_qc>October 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Comprehensive and Integrative Medicine Institute of South Korea</investigator_affiliation>
    <investigator_full_name>Hyun jung, Jung</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

